Bioprocessing - Upstream & Downstream

What lies ahead for biopharma manufacturers when it comes to downstream analytical tech?

While contamination issues continue to limit the potential of gene therapy, scientists can no longer afford to ignore the best detection methods.

Who are the most influential and inspirational people in drug development and manufacturing? Nominations for the Power List 2024 are now open!

We interview Clayton Weber, Systems Engineering Lead/ Sustainability Lead at Asahi Kasei Bioprocess

Understanding AAV production and characterization processes – and establishing strategies for success.

How increased biological understanding and advanced technology are generating new antibody-based modalities with exciting potential.

How fucosylation-deficient CHO cell hosts can help enhance the potency of monoclonal antibody-based biotherapeutics

The wait is over. Our annual celebration of the pharma industry’s most influential individuals has returned!

From resins to buffers to single-use technologies – there are many opportunities to improve downstream processes.

How the thoughtful adoption of new technology can both problem-solve and future- proof critical processes in biomanufacturing